Search | Webyourself Social Media Platform

Naufan Cmi added article Health
2023-10-30 10:38:46 -

North America segment contributes over 35% of global buprenorphine market share
Market Overview: The global buprenorphine market is estimated to be valued at US$ 3,681.9 million in 2022 and is expected to exhibit a CAGR of 14.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Buprenorphine is a partial opioid agonist used to treat opioid addiction and pain. It provides an effective alternative to methadone for...

0 Comments 0 Shares 1525 Views 0 Reviews

Please log in to like, share and comment!
Tushar Jane added article Other
2024-11-22 06:32:29 -

Buprenorphine Hydrochloride Market Report 2024 - Industry Outlook
The Global Buprenorphine Hydrochloride Market research report enlists the vital and practical information with regards to market situation. The present scenario of Buprenorphine Hydrochloride market, along with its previous performance as well as future scope are covered in the Buprenorphine Hydrochloride report. This eases the user’s understanding of the market thoroughly,...

0 Comments 0 Shares 37 Views 0 Reviews

Please log in to like, share and comment!
Gauri Kanale added article Other
2024-03-01 11:38:37 -

Buprenorphine Market Growth Is Driven By Increasing Prescription Of Opioid Addiction Therapy
The Buprenorphine Market comprises products such as sublingual tablets, buccal films, implants and injections that are used for the treatment of opioid addiction and pain management. Buprenorphine is a partial opioid agonist that helps in controlling opioid cravings and reducing the associated risks of opioid dependence. It provides an alternative to methadone for patients diagnosed with opioid...

0 Comments 0 Shares 1206 Views 0 Reviews

Please log in to like, share and comment!
Gauri Kanale added article Other
2024-03-01 11:38:38 -

Buprenorphine Market Growth Is Driven By Increasing Prescription Of Opioid Addiction Therapy
The Buprenorphine Market comprises products such as sublingual tablets, buccal films, implants and injections that are used for the treatment of opioid addiction and pain management. Buprenorphine is a partial opioid agonist that helps in controlling opioid cravings and reducing the associated risks of opioid dependence. It provides an alternative to methadone for patients diagnosed with opioid...

0 Comments 0 Shares 1179 Views 0 Reviews

Please log in to like, share and comment!
Kajal Patil added article Health
2024-07-11 13:30:36 -

Buprenorphine Market Size, Analysis and Forecast 2031
The Buprenorphine Market in 2023 is US$ 5.51 billion, and is expected to reach US$ 17.1 billion by 2031 at a CAGR of 15.20%. FutureWise Research published a report that analyzes Buprenorphine Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and...

0 Comments 0 Shares 563 Views 0 Reviews

Please log in to like, share and comment!
Sushil Sushil added article Other
2024-01-26 08:50:27 -

Opioid Addiction Treatment Market To Witness High Growth Driven By Expanding Patient Base And Increasing R&D Activities
Buprenorphine is an opioid medication primarily used to treat opioid use disorder, acute pain, and chronic pain. It is typically taken under the tongue as a film, tablet, or as an injection. Buprenorphine helps to relieve cravings and withdrawal symptoms associated with opioid addiction. The medication works by activating opioid receptors in the brain to relieve pain and reduce opioid cravings...

0 Comments 0 Shares 1361 Views 0 Reviews

Please log in to like, share and comment!